Naimish Patel

Companies

• AgomAb Therapeutics NVBoard member Sep 15, 2026 to now¹
• CRISPR TherapeuticsChief Medical Officer May 28, 2024 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CRISPR Therapeutics CRSP19,357 shares³$966.1K at $49.91May 29, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 29, 2026Sold 3,786 shares at $55.62 of CRISPR Therapeutics³
• May 28, 2026Exercised options 10,000 shares of CRISPR Therapeutics³
• Mar 16, 2026Sold 3,150 shares at $48.26 of CRISPR Therapeutics⁴
• Mar 14, 2026Exercised options 8,125 shares of CRISPR Therapeutics⁴
• May 29, 2025Sold 3,932 shares at $35.94 of CRISPR Therapeutics⁵
• May 28, 2025Exercised options 10,000 shares of CRISPR Therapeutics⁵
• Apr 3, 2025Bought 1,508 shares at $32.96 of CRISPR Therapeutics⁶